oxybutynin has been researched along with Cerebral Palsy, Athetoid in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drooling is common in children with neurological disorders, but its management is very challenging, Scopolamine transdermal patch (STP) appears to be useful in controlling drooling, although it is not approved for this indication and there are limited clinical studies about its effectiveness." | 1.56 | Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital. ( Abolfotouh, MA; Al Jeraisy, M; AlFuraih, M; AlKhalifah, B; AlOtaibi, H; AlSaif, R, 2020) |
| "Oxybutynin has less anticholinergic activity than propantheline bromide." | 1.28 | Oxybutynin-induced reflux esophagitis. ( Lee, M; Sharifi, R, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, M | 1 |
| Sharifi, R | 1 |
| Al Jeraisy, M | 1 |
| AlFuraih, M | 1 |
| AlSaif, R | 1 |
| AlKhalifah, B | 1 |
| AlOtaibi, H | 1 |
| Abolfotouh, MA | 1 |
| Chowdhury, NA | 1 |
| Sewatsky, ML | 1 |
| Kim, H | 1 |
3 other studies available for oxybutynin and Cerebral Palsy, Athetoid
| Article | Year |
|---|---|
Oxybutynin-induced reflux esophagitis.
Topics: Adult; Cerebral Palsy; Esophagitis, Peptic; Female; Humans; Mandelic Acids; Parasympatholytics | 1990 |
Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital.
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Humans; Retrospective Studies; Saudi Arabia; Sc | 2020 |
Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Topics: Adolescent; Antiemetics; Botulinum Toxins, Type A; Cerebral Palsy; Delayed Diagnosis; Humans; Inject | 2017 |